[Protective effect of knock-down the expression of Blimp1 gene on early liver injury in CCl4-induced mouse model of liver fibrosis].

Q3 Medicine
北京大学学报(医学版) Pub Date : 2025-08-18
Q Qin, R Li, Y Zhou, Y Zhang, M Han, L Zhu
{"title":"[Protective effect of knock-down the expression of <i>Blimp1</i> gene on early liver injury in CCl<sub>4</sub>-induced mouse model of liver fibrosis].","authors":"Q Qin, R Li, Y Zhou, Y Zhang, M Han, L Zhu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To explore the protective effect of knock-down the expression of B lymphocyte induced maturation protein 1 (<i>Blimp1</i>) gene on early liver injury in carbon tetrachloride (CCl<sub>4</sub>)-induced mouse model of liver fibrosis.</p><p><strong>Methods: </strong>C57BL/6 mice were intraderitoneal injected with 5% CCl<sub>4</sub> olive oil solution to create mouse model of hepatic fibrosis. The expression of <i>Blimp1</i> gene in the mice was reduced by intraderitoneal injection of short hairpin RNA (shRNA) adeno-associated virus (AAV). The mice were randomly divided into 3 groups: blank test group (<i>n</i>=10), CCl<sub>4</sub>+AAV-shRNA-NC group (<i>n</i>=10) and CCl<sub>4</sub>+AAV-shRNA-Blimp1 group (<i>n</i>=10). After 27 days of preparation of the CCl<sub>4</sub> mouse model, animal materials were carried out. Western blot and real-time PCR were used to detect the levels of Blimp1, α-smooth muscle actin (α-SMA), collagen type Ⅰ alpha 1 (COL1A1), collagen type Ⅲ alpha 1 (COL3A1), and their mRNA expression levels of liver tissue in each group. The serum of each group was separated to measure aspartate transaminase (AST) and alanine transaminase (ALT) by automatic biochemical analyzer. The pathological changes of liver tissue and the degree of liver fibrosis in the mice were detected by pathological staining including hematoxylin-eosin staining, Masson, and Sirius red.</p><p><strong>Results: </strong>The expression levels of Blimp1 protein in the liver of CCl<sub>4</sub>+AAV-shRNA-NC group (2.036±0.244, <i>t</i>=3.690, <i>P</i>=0.002) were significantly increased than that of the blank test group. In the CCl<sub>4</sub>+AAV-shRNA-Blimp1 group, the expression of Blimp1 protein decreased to the basal level (0.783±0.249, <i>t</i>=6.223, <i>P</i>=0.003). Compared with the serum levels of ALT [(1 957.8±633.6) U/L] and AST [(1 808.8±260.1) U/L] in the CCl<sub>4</sub>+AAV-shRNA-NC group, the serum levels of ALT [(894.0±360.1) U/L, <i>t</i>=3.998, <i>P</i>=0.003] and AST [(820.0±100.6) U/L, <i>t</i>=6.141, <i>P</i>=0.004] in the CCl<sub>4</sub>+AAV-shRNA-Blimp1 group were significantly decreased. The pathological results of the CCl<sub>4</sub>+AAV-shRNA-Blimp1 group showed that compared with the CCl<sub>4</sub>+AAV-shRNA-NC group, the infiltration of inflammatory cells in the liver tissue was reduced and the degree of fibrosis was alleviated. The level of α-SMA (0.676±0.064, <i>t</i>=7.930, <i>P</i>=0.001), COL1A1 (1.426±0.143, <i>t</i>=6.364, <i>P</i>=0.003) and COL3A1 (1.124±0.198, <i>t</i>=3.440, <i>P</i>=0.026) of liver in the CCl<sub>4</sub>+AAV-shRNA-Blimp1 group were significantly decreased than that of CCl<sub>4</sub>+AAV-shRNA-NC group, and the mRNA expression levels were altered as well as their protein levels.</p><p><strong>Conclusion: </strong>Blimp1 plays an important role in CCl<sub>4</sub>-induced liver fibrosis in mice, and knock-down the expression of <i>Blimp1</i> gene is beneficial to protect early liver injury in mice.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 4","pages":"727-734"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12330913/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"北京大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To explore the protective effect of knock-down the expression of B lymphocyte induced maturation protein 1 (Blimp1) gene on early liver injury in carbon tetrachloride (CCl4)-induced mouse model of liver fibrosis.

Methods: C57BL/6 mice were intraderitoneal injected with 5% CCl4 olive oil solution to create mouse model of hepatic fibrosis. The expression of Blimp1 gene in the mice was reduced by intraderitoneal injection of short hairpin RNA (shRNA) adeno-associated virus (AAV). The mice were randomly divided into 3 groups: blank test group (n=10), CCl4+AAV-shRNA-NC group (n=10) and CCl4+AAV-shRNA-Blimp1 group (n=10). After 27 days of preparation of the CCl4 mouse model, animal materials were carried out. Western blot and real-time PCR were used to detect the levels of Blimp1, α-smooth muscle actin (α-SMA), collagen type Ⅰ alpha 1 (COL1A1), collagen type Ⅲ alpha 1 (COL3A1), and their mRNA expression levels of liver tissue in each group. The serum of each group was separated to measure aspartate transaminase (AST) and alanine transaminase (ALT) by automatic biochemical analyzer. The pathological changes of liver tissue and the degree of liver fibrosis in the mice were detected by pathological staining including hematoxylin-eosin staining, Masson, and Sirius red.

Results: The expression levels of Blimp1 protein in the liver of CCl4+AAV-shRNA-NC group (2.036±0.244, t=3.690, P=0.002) were significantly increased than that of the blank test group. In the CCl4+AAV-shRNA-Blimp1 group, the expression of Blimp1 protein decreased to the basal level (0.783±0.249, t=6.223, P=0.003). Compared with the serum levels of ALT [(1 957.8±633.6) U/L] and AST [(1 808.8±260.1) U/L] in the CCl4+AAV-shRNA-NC group, the serum levels of ALT [(894.0±360.1) U/L, t=3.998, P=0.003] and AST [(820.0±100.6) U/L, t=6.141, P=0.004] in the CCl4+AAV-shRNA-Blimp1 group were significantly decreased. The pathological results of the CCl4+AAV-shRNA-Blimp1 group showed that compared with the CCl4+AAV-shRNA-NC group, the infiltration of inflammatory cells in the liver tissue was reduced and the degree of fibrosis was alleviated. The level of α-SMA (0.676±0.064, t=7.930, P=0.001), COL1A1 (1.426±0.143, t=6.364, P=0.003) and COL3A1 (1.124±0.198, t=3.440, P=0.026) of liver in the CCl4+AAV-shRNA-Blimp1 group were significantly decreased than that of CCl4+AAV-shRNA-NC group, and the mRNA expression levels were altered as well as their protein levels.

Conclusion: Blimp1 plays an important role in CCl4-induced liver fibrosis in mice, and knock-down the expression of Blimp1 gene is beneficial to protect early liver injury in mice.

[敲除Blimp1基因表达对ccl4诱导的肝纤维化小鼠早期肝损伤的保护作用]。
目的:探讨敲低B淋巴细胞诱导成熟蛋白1 (Blimp1)基因表达对四氯化碳(CCl4)诱导的肝纤维化小鼠早期肝损伤的保护作用。方法:C57BL/6小鼠腹腔注射5% CCl4橄榄油溶液,建立小鼠肝纤维化模型。腹腔注射短发夹RNA (shRNA)腺相关病毒(AAV)可降低小鼠Blimp1基因的表达。将小鼠随机分为3组:空白试验组(n=10)、CCl4+AAV-shRNA-NC组(n=10)和CCl4+AAV-shRNA-Blimp1组(n=10)。CCl4小鼠模型制备27 d后,进行动物材料制备。采用Western blot和real-time PCR检测各组大鼠肝组织中Blimp1、α-平滑肌肌动蛋白(α-SMA)、胶原型Ⅰα 1 (COL1A1)、胶原型Ⅲα 1 (COL3A1) mRNA表达水平。各组分离血清,采用全自动生化分析仪测定天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)。采用苏木精-伊红染色、马松染色、天狼星红等病理染色检测小鼠肝组织病理变化及肝纤维化程度。结果:CCl4+AAV-shRNA-NC组Blimp1蛋白在肝脏中的表达水平(2.036±0.244,t=3.690, P=0.002)显著高于空白试验组。CCl4+AAV-shRNA-Blimp1组Blimp1蛋白表达量降至基础水平(0.783±0.249,t=6.223, P=0.003)。与CCl4+AAV-shRNA-NC组血清ALT[(1 957.8±633.6)U/L]和AST[(1 808.8±260.1)U/L]水平相比,CCl4+AAV-shRNA-Blimp1组血清ALT[(894.0±360.1)U/L, t=3.998, P=0.003]和AST[(820.0±100.6)U/L, t=6.141, P=0.004]水平显著降低。CCl4+AAV-shRNA-Blimp1组病理结果显示,与CCl4+AAV-shRNA-NC组相比,肝组织炎症细胞浸润减少,纤维化程度减轻。与CCl4+AAV-shRNA-NC组相比,CCl4+AAV-shRNA-Blimp1组肝脏α-SMA(0.676±0.064,t=7.930, P=0.001)、COL1A1(1.426±0.143,t=6.364, P=0.003)、COL3A1(1.124±0.198,t=3.440, P=0.026)水平显著降低,mRNA表达水平及蛋白水平发生改变。结论:Blimp1在ccl4诱导的小鼠肝纤维化中起重要作用,敲低Blimp1基因的表达有利于保护小鼠早期肝损伤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
北京大学学报(医学版)
北京大学学报(医学版) Medicine-Medicine (all)
CiteScore
0.80
自引率
0.00%
发文量
9815
期刊介绍: Beijing Da Xue Xue Bao Yi Xue Ban / Journal of Peking University (Health Sciences), established in 1959, is a national academic journal sponsored by Peking University, and its former name is Journal of Beijing Medical University. The coverage of the Journal includes basic medical sciences, clinical medicine, oral medicine, surgery, public health and epidemiology, pharmacology and pharmacy. Over the last few years, the Journal has published articles and reports covering major topics in the different special issues (e.g. research on disease genome, theory of drug withdrawal, mechanism and prevention of cardiovascular and cerebrovascular diseases, stomatology, orthopaedic, public health, urology and reproductive medicine). All the topics involve latest advances in medical sciences, hot topics in specific specialties, and prevention and treatment of major diseases. The Journal has been indexed and abstracted by PubMed Central (PMC), MEDLINE/PubMed, EBSCO, Embase, Scopus, Chemical Abstracts (CA), Western Pacific Region Index Medicus (WPR), JSTChina, and almost all the Chinese sciences and technical index systems, including Chinese Science and Technology Paper Citation Database (CSTPCD), Chinese Science Citation Database (CSCD), China BioMedical Bibliographic Database (CBM), CMCI, Chinese Biological Abstracts, China National Academic Magazine Data-Base (CNKI), Wanfang Data (ChinaInfo), etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信